The Business Journal on WFDD: How a Triad company could help Alzheimer's ... - The Business Journal of the Greater Triad Area (blog)

Enlarge

Julie Knight

TransTech Pharma is launching its Phase 3 clinical trial in the battle against Alzheimer’s.

While incidences of Alzheimer's disease continue to rise in the U.S., a Triad company's drug may be the first effective treatment for a disease that has robbed millions of people of their memories and lives.

The drug has the potential to delay the onset of Alzheimer's and High Point's TransTech Pharma recently submitted the protocol to the FDA outlining its plans for a Phase 3 clinical trial of the drug.

Learn more about the drug's potential from an on-air discussion^[1] between Business Journal contributor Justin Catanoso^[2] and WFDD's Audrey Fannin^[3] . Read more from Reporter Matt Evans' story in The Business Journal ^[4] about what it would mean for TransTech Pharma.

Amy Dominello Braun manages Web content, social media and awards-based special sections for The Business Journal.

References

1. ^{^} an on-air discussion (wfdd.org)


2. ^{^} Justin Catanoso (www.bizjournals.com)


3. ^{^} Audrey Fannin (www.bizjournals.com)


4. ^{^} Read more from Reporter Matt Evans' story in The Business Journal (www.bizjournals.com)